Vensun Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.48 Cr
- Revenue Growth 38.06%
- Profit Growth -11.85%
- Ebitda 15.71%
- Net Worth 6.15%
- Total Assets 41.03%
About Vensun Laboratories
Vensun Laboratories Private Limited (VLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 October 2008 and has a history of 16 years and three months. Its registered office is in Solapur, Maharashtra, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹10.48 Cr.
Abhishek Mathur, Komal Mathur, and Mithlesh Mathur serve as directors at the Company.
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100PN2008PTC132942
- Company No.
132942
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2008
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Vensun Laboratories?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mithlesh Mathur | Additional Director | 16-Oct-2014 | Current |
Abhishek Mathur | Director | 01-Apr-2020 | Current |
Komal Mathur | Additional Director | 16-Oct-2014 | Current |
Financial Performance of Vensun Laboratories.
Vensun Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.06% increase. The company also saw a substantial fall in profitability, with a 11.85% decrease in profit. The company's net worth moved up by a moderate rise of 6.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Vensun Laboratories?
In 2023, Vensun Laboratories had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.48 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 7.00 Cr
- Bank Of Maharashtra : 3.48 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
23 Sep 2022 | Others | ₹7.00 Cr | Open |
21 Jun 2011 | Bank Of Maharashtra | ₹3.48 Cr | Open |
How Many Employees Work at Vensun Laboratories?
Unlock and access historical data on people associated with Vensun Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vensun Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vensun Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.